There are 2789 resources available
1025TiP - SOLTI-1904: Efficacy of spartalizumab across multiple cancer-types in patients with PD1-high mRNA expressing tumors defined by a single and pre-specified cutoff (ACROPOLI)
Presenter: Aleix Prat
Session: ePoster Display
1026TiP - A phase Ib/II, open-label, multicenter, dose-escalation and dose-expansion study of NKTR-255 plus cetuximab as a salvage regimen in patients with solid tumors
Presenter: Mehmet Altan
Session: ePoster Display
1027TiP - A phase Ib study of CM24 in combination with nivolumab in adults with advanced solid tumors, followed by a phase IIa study of CM24 in combination with nivolumab in NSCLC, and in combination with nivolumab and nab-paclitaxel in pancreatic cancer
Presenter: Erkut Borazanci
Session: ePoster Display
1067P - Correlation between the number of risk factors and relapse in patients with cutaneous squamous cell carcinoma: A predictive factor for accurate adjuvant radiotherapy?
Presenter: Adeline Petre
Session: ePoster Display
1068P - Efficacy of combined hypo-fractionated radiotherapy (RT) in anti-PD-1 monotherapy-treated melanoma pts
Presenter: Philippe Saiag
Session: ePoster Display
1070P - Adjuvant treatment for melanoma in clinical practice: Trial versus reality
Presenter: Melissa De Meza
Session: ePoster Display
1122TiP - A phase II trial to evaluate the safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), pheochromocytomas and paragangliomas (PPGLs)
Presenter: Mark Gaze
Session: ePoster Display
1125P - Analytical assessment of a diagnostic immunohistochemical assay for the detection of folate receptor-ɑ in epithelial ovarian cancers
Presenter: Racheal James
Session: ePoster Display
1126P - Budget impact of Oncotype DX test compared to further gene expression tests in patients with early breast cancer in Germany
Presenter: Michael Lux
Session: ePoster Display